Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data

Lancet Neurology

Volumn 6, Issue 4, 2007, Pages 322-328

  Schymick, Jennifer C ^a,i   Scholz, Sonja W ^a,c   Fung, Hon Chung ^a,c   Britton, Angela ^a   Arepalli, Sampath ^a   Gibbs, J Raphael ^a,c   Lombardo, Federica ^d   Matarin, Mar ^a   Kasperaviciute, Dalia ^c   Hernandez, Dena G ^a   Crews, Cynthia ^a   Bruijn, Lucie ^e   Rothstein, Jeffrey ^f   Mora, Gabriele ^g   Restagno, Gabriella ^d   Chiò, Adriano ^h   Singleton, Andrew ^a   Hardy, John ^a   Traynor, Bryan J ^b,f  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d OIRM S Anna   (Italy)

^e ALS Association   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g IRCCS   (Italy)

^h UNIVERSITY OF TURIN   (Italy)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME; GENOTYPE; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUBLIC HEALTH; SAMPLE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; DATABASES, GENETIC; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOMIC LIBRARY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR BIOLOGY; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLIC SECTOR; REFERENCE VALUES;

EID: 33847622526     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(07)70037-6     Document Type: Article

References (44)

1. Monk P., and Shaw P. ALS: life and death in a bad neighborhood. Nat Med 12 (2006) 885-887
2. The Scottish Motor Neuron Disease Register. A prospective study of adult onset motor neuron disease in Scotland: methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry 55 (1992) 536-541
3. Traynor B., Codd M., Corr B., et al. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology 52 (1999) 504-509
4. Logroscino G., Beghi E., Zoccolella S., et al. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry 76 (2005) 1094-1098
5. Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology 56 (2001) 239-244
6. Rosen D., Siddique T., Patterson D., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
7. Puls I., Jonnakuty C., LaMonte B., et al. Mutant dynactin in motor neuron disease. Nat Genet 33 (2003) 455-456
8. Munch C., Sedlmeier R., Meyer T., et al. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 63 (2004) 724-726
9. Hadano S., Hand C., Osuga H., et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 29 (2001) 166-173
10. Chen Y., Bennett C., Huynh H., et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet 74 (2004) 1128-1135
11. Nishimura A., Mitne-Neto M., Silva H., et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet 75 (2004) 822-831
12. Greenway M., Alexander M., Ennis S., et al. A novel candidate region for ALS on chromosome 14q11.2. Neurology 63 (2004) 1936-1938
13. Greenway M., Andersen P., Russ C., et al. ANG mutations segregate with familial and sporadic amyotrophic lateral sclerosis. Nat Genet 38 (2006) 411-413
14. The International HapMap Consortium. The International HapMap Project. Nature 426 (2003) 789-796
15. The International HapMap Consortium. A haplotype map of the human genome. Nature 437 (2005) 1299-1320
16. Fan J., Chee M., and Gunderson K. Highly parallel genomic assays. Nat Rev Genet 7 (2006) 632-644
17. Fung H., Scholz S., Matarin M., et al. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 5 (2006) 911-916
18. Carlson C., Eberle M., Rieder M., et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74 (2004) 106-120
19. Brooks B., Miller R., Swash M., and Munsat T. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1 (2000) 293-299
20. Miller G., Shope T., Lisco H., Stitt D., and Lipman M. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc Natl Acad Sci USA 69 (1972) 383-387
21. Simon-Sanchez J., Scholz S., Fung H., et al. Genome-wide SNP assay reveals structural genomic variation, extended homozygosity and cell-line induced alterations in normal individuals. Hum Mol Genet 16 (2007) 1-14
22. Falush D., Stephens M., and Pritchard J. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164 (2003) 1567-1587
23. Sutedja N., Sinke R., Van Vught P., et al. The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch population. Arch Neurol 64 (2007) 63-67
24. Goodall E., Greenway M., van Marion I., et al. Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS. Neurology 65 (2005) 934-937
25. Restagno G, Lombardo F, Ghiglione P, et al. HFE H63D polymorphism is increased in ALS patients of Italian origin. J Neurol Neurosurg Psychiatry (in press).
26. Freedman M., Reich D., Penney K., et al. Assessing the impact of population stratification on genetic association studies. Nat Genet 36 (2004) 388-393
27. Liu X., Paterson A., John E., and Knight J. The role of self-defined race/ethnicity in population structure control. Ann Hum Genet 70 (2006) 496-505
28. Rosenberg N., Pritchard J., Weber J., et al. Genetic structure of human populations. Science 298 (2002) 2381-2385
29. Pritchard J., Stephens M., and Donnelly P. Inference of population structure using multilocus genotype data. Genetics 155 (2000) 945-959
30. Conrad D., Jakobsson M., Coop G., et al. A worldwide survey of haplotype variation and linkage disequilibrium in the human genome. Nat Genet 38 (2006) 1251-1260
31. Varilo T., and Peltonen L. Isolates and their potential use in complex gene mapping efforts. Curr Opin Genet Dev 14 (2004) 316-323
32. Van Steen K., McQueen M., Herbert A., et al. Genomic screening and replication using the same data set in family-based association testing. Nat Genet 37 (2005) 683-691
33. Hildebrand J., and Soriano P. Shroom, a PDZ domain-containing actin-binding protein, is required for neural tube morphogenesis in mice. Cell 99 (1999) 485-497
34. Katoh H., and Negishi M. RhoG activates Rac1 by direct interaction with the Dock180-binding protein Elmo. Nature 424 (2003) 461-464
35. Zhao C., Takita J., Tanaka Y., et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105 (2001) 587-597
36. Conforti F., Sprovieri T., Mazzei R., et al. Sporadic ALS is not associated with VAPB gene mutations in Southern Italy. J Negat Results Biomed 5 (2006) 7
37. Hand C., Devon R., Gros-Louis F., et al. Mutation screening of the ALS2 gene in sporadic and familial amyotrophic lateral sclerosis. Arch Neurol 60 (2003) 1768-1771
38. Battistini S., Giannini F., Greco G., et al. SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study. J Neurol 252 (2005) 782-788
39. Klein R., Zeiss C., Chew E., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
40. Maraganore D., de Andrade M., Lesnick T., et al. High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 77 (2005) 685-693
41. Elbaz A., Nelson L., Payami H., et al. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurol 5 (2006) 917-923
42. Farrer M., Haugarvoll K., Ross O., et al. Genomewide association, Parkinson disease, and PARK10. Am J Hum Genet 78 (2006) 1084-1088
43. Goris A., Williams-Gray C., Foltynie T., et al. No evidence for association with Parkinson disease for 13 single-nucleotide polymorphisms identified by whole-genome association screening. Am J Hum Genet 78 (2006) 1088-1090
44. Li Y., Rowland C., Schrodi S., et al. A case-control association study of the 12 single-nucleotide polymorphisms implicated in Parkinson disease by a recent genome scan. Am J Hum Genet 78 (2006) 1090-1092